Ashland Reaches New 52-Week High (ASH)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Ashland (NYSE: ASH) hit a new 52-week high Tuesday as it is currently trading at $78.63, above its previous 52-week high of $78.62 with 184,415 shares traded as of 11:01 a.m. ET. Average volume has been 808,600 shares over the past 30 days.

Ashland has a market cap of $5.98 billion and is part of the basic materials sector and chemicals industry. Shares are up 32.5% year to date as of the close of trading on Monday.

Ashland Inc. operates as a specialty chemicals company in the United States and internationally. It operates through four segments: Specialty Ingredients, Water Technologies, Performance Materials, and Consumer Markets. The company has a P/E ratio of 157.8, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Ashland as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and poor profit margins. You can view the full Ashland Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE: Sign up today to get e-mail alerts before every trade.
null

If you liked this article you might like

'Mad Money' Lightning Round: Southwestern Energy, UnitedHealth, Celgene and More

Jim Cramer's 'Mad Money' Recap: Don't Worry About a Little Market Detour

2 Specialty Chemical Stocks With Breakout Potential

3 Stocks Improving Performance Of The Chemicals Industry

Analysts' Actions -- Activision, Garmin, Match, Sirius and More